897 related articles for article (PubMed ID: 20646177)
1. Puberty suppression in adolescents with gender identity disorder: a prospective follow-up study.
de Vries AL; Steensma TD; Doreleijers TA; Cohen-Kettenis PT
J Sex Med; 2011 Aug; 8(8):2276-83. PubMed ID: 20646177
[TBL] [Abstract][Full Text] [Related]
2. Psychological Support, Puberty Suppression, and Psychosocial Functioning in Adolescents with Gender Dysphoria.
Costa R; Dunsford M; Skagerberg E; Holt V; Carmichael P; Colizzi M
J Sex Med; 2015 Nov; 12(11):2206-14. PubMed ID: 26556015
[TBL] [Abstract][Full Text] [Related]
3. Young adult psychological outcome after puberty suppression and gender reassignment.
de Vries AL; McGuire JK; Steensma TD; Wagenaar EC; Doreleijers TA; Cohen-Kettenis PT
Pediatrics; 2014 Oct; 134(4):696-704. PubMed ID: 25201798
[TBL] [Abstract][Full Text] [Related]
4. Gonadal suppressive and cross-sex hormone therapy for gender dysphoria in adolescents and adults.
Smith KP; Madison CM; Milne NM
Pharmacotherapy; 2014 Dec; 34(12):1282-97. PubMed ID: 25220381
[TBL] [Abstract][Full Text] [Related]
5. Puberty suppression in gender identity disorder: the Amsterdam experience.
Kreukels BP; Cohen-Kettenis PT
Nat Rev Endocrinol; 2011 May; 7(8):466-72. PubMed ID: 21587245
[TBL] [Abstract][Full Text] [Related]
6. Management of juvenile gender dysphoria.
Hembree WC
Curr Opin Endocrinol Diabetes Obes; 2013 Dec; 20(6):559-64. PubMed ID: 24468758
[TBL] [Abstract][Full Text] [Related]
7. Back to the Future: Is GnRHa Treatment in Transgender and Gender Diverse Adolescents Only an Extended Evaluation Phase?
Fisher AD; Ristori J; Romani A; Cassioli E; Mazzoli F; Cocchetti C; Pierdominici M; Marconi M; Ricca V; Maggi M; Vignozzi L; Castellini G
J Clin Endocrinol Metab; 2024 May; 109(6):1565-1579. PubMed ID: 38099569
[TBL] [Abstract][Full Text] [Related]
8. Treatment of adolescents with gender dysphoria in the Netherlands.
Cohen-Kettenis PT; Steensma TD; de Vries AL
Child Adolesc Psychiatr Clin N Am; 2011 Oct; 20(4):689-700. PubMed ID: 22051006
[TBL] [Abstract][Full Text] [Related]
9. Guidelines for pubertal suspension and gender reassignment for transgender adolescents.
Hembree WC
Child Adolesc Psychiatr Clin N Am; 2011 Oct; 20(4):725-32. PubMed ID: 22051008
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of Gonadotropin-Releasing Hormone Agonist Treatment to Suppress Puberty in Gender Dysphoric Adolescents.
Schagen SE; Cohen-Kettenis PT; Delemarre-van de Waal HA; Hannema SE
J Sex Med; 2016 Jul; 13(7):1125-32. PubMed ID: 27318023
[TBL] [Abstract][Full Text] [Related]
11. Transition memories: experiences of trans adult women with hormone therapy and their beliefs on the usage of hormone blockers to suppress puberty.
Giovanardi G; Morales P; Mirabella M; Fortunato A; Chianura L; Speranza AM; Lingiardi V
J Endocrinol Invest; 2019 Oct; 42(10):1231-1240. PubMed ID: 30953318
[TBL] [Abstract][Full Text] [Related]
12. Children and adolescents in the Amsterdam Cohort of Gender Dysphoria: trends in diagnostic- and treatment trajectories during the first 20 years of the Dutch Protocol.
van der Loos MATC; Klink DT; Hannema SE; Bruinsma S; Steensma TD; Kreukels BPC; Cohen-Kettenis PT; de Vries ALC; den Heijer M; Wiepjes CM
J Sex Med; 2023 Feb; 20(3):398-409. PubMed ID: 36763938
[TBL] [Abstract][Full Text] [Related]
13. Bone mass in young adulthood following gonadotropin-releasing hormone analog treatment and cross-sex hormone treatment in adolescents with gender dysphoria.
Klink D; Caris M; Heijboer A; van Trotsenburg M; Rotteveel J
J Clin Endocrinol Metab; 2015 Feb; 100(2):E270-5. PubMed ID: 25427144
[TBL] [Abstract][Full Text] [Related]
14. A Longitudinal Study of Features Associated with Autism Spectrum in Clinic Referred, Gender Diverse Adolescents Accessing Puberty Suppression Treatment.
Russell I; Pearson B; Masic U
J Autism Dev Disord; 2021 Jun; 51(6):2068-2076. PubMed ID: 32936414
[TBL] [Abstract][Full Text] [Related]
15. Changes in Adrenal Androgens During Puberty Suppression and Gender-Affirming Hormone Treatment in Adolescents With Gender Dysphoria.
Schagen SEE; Lustenhouwer P; Cohen-Kettenis PT; Delemarre-van de Waal HA; Hannema SE
J Sex Med; 2018 Sep; 15(9):1357-1363. PubMed ID: 30224022
[TBL] [Abstract][Full Text] [Related]
16. The peripubertal gender-dysphoric child: puberty suppression and treatment paradigms.
Olson J; Garofalo R
Pediatr Ann; 2014 Jun; 43(6):e132-7. PubMed ID: 24972421
[TBL] [Abstract][Full Text] [Related]
17. Hormone treatment of gender identity disorder in a cohort of children and adolescents.
Hewitt JK; Paul C; Kasiannan P; Grover SR; Newman LK; Warne GL
Med J Aust; 2012 May; 196(9):578-81. PubMed ID: 22621149
[TBL] [Abstract][Full Text] [Related]
18. Puberty suppression and executive functioning: An fMRI-study in adolescents with gender dysphoria.
Staphorsius AS; Kreukels BP; Cohen-Kettenis PT; Veltman DJ; Burke SM; Schagen SE; Wouters FM; Delemarre-van de Waal HA; Bakker J
Psychoneuroendocrinology; 2015 Jun; 56():190-9. PubMed ID: 25837854
[TBL] [Abstract][Full Text] [Related]
19. Bone Development in Transgender Adolescents Treated With GnRH Analogues and Subsequent Gender-Affirming Hormones.
Schagen SEE; Wouters FM; Cohen-Kettenis PT; Gooren LJ; Hannema SE
J Clin Endocrinol Metab; 2020 Dec; 105(12):e4252-63. PubMed ID: 32909025
[TBL] [Abstract][Full Text] [Related]
20. To treat or not to treat: puberty suppression in childhood-onset gender dysphoria.
Costa R; Carmichael P; Colizzi M
Nat Rev Urol; 2016 Aug; 13(8):456-62. PubMed ID: 27431339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
